| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
-Induced Cell Death
1 Laboratoire de Cytokines et Immunologie des Tumeurs Humaines, Institut National de la Santé et de la Recherche Médicale U-487, Institut Gustave Roussy Pavillon de Recherche 1 and Institut Fédératif de Recherche, Villejuif, France;
2 Unité Mixte de Recherche 1161 de Virologie Institut National de Recherche Agronomique Agence Française de Sécurité Sanitaire des Aliments École National Vétérinaire dAlfort, Maisons Alfort, France;
3 Commisariat à lÉnergie Atomique, Service de Génomique Fonctionnelle, Evry, France;
4 Unité Mixte de Recherche 8125 Centre National de la Recherche Scientifique, Institut Gustave Roussy Pavillon de Recherche 2, Villejuif, France; and
5 Commisariat à lÉnergie Atomique, Service de Neurovirologie, Centre de Recherche du Service Santé des Armés, École Pratique des Hautes Études, Institut Paris sud sur les Cytokines, Université Paris XI, Fontenay-aux-Roses, France
To define genetic determinants of tumor cell resistance to the cytotoxic action of tumor necrosis factor
(TNF), we have applied cDNA microarrays to a human breast carcinoma TNF-sensitive MCF7 cell line and its established TNF-resistant clone. Of a total of 5760 samples of cDNA examined, 3.6% were found to be differentially expressed in TNF-resistant 1001 cells as compared with TNF-sensitive MCF7 cells. On the basis of available literature data, the striking finding is the association of some differentially expressed genes involved in the phosphatidylinositol-3-kinase/Akt signaling pathway. More notably, we found that the PRNP gene coding for the cellular prion protein (PrPc), was 17-fold overexpressed in the 1001 cell line as compared with the MCF7 cell line. This differential expression was confirmed at the cell surface by immunostaining that indicated that PrPc is overexpressed at both mRNA and protein levels in the TNF-resistant derivative. Using recombinant adenoviruses expressing the human PrPc, our data demonstrate that PrPc overexpression converted TNF-sensitive MCF7 cells into TNF-resistant cells, at least in part, by a mechanism involving alteration of cytochrome c release from mitochondria and nuclear condensation.
This article has been cited by other articles:
![]() |
R. Linden, V. R. Martins, M. A. M. Prado, M. Cammarota, I. Izquierdo, and R. R. Brentani Physiology of the Prion Protein Physiol Rev, April 1, 2008; 88(2): 673 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Meslin, A. Hamai, P. Gao, A. Jalil, N. Cahuzac, S. Chouaib, and M. Mehrpour Silencing of Prion Protein Sensitizes Breast Adriamycin-Resistant Carcinoma Cells to TRAIL-Mediated Cell Death Cancer Res., November 15, 2007; 67(22): 10910 - 10919. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Meslin, R. Conforti, C. Mazouni, N. Morel, G. Tomasic, F. Drusch, M. Yacoub, J. C. Sabourin, J. Grassi, S. Delaloge, et al. Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer Ann. Onc., November 1, 2007; 18(11): 1793 - 1798. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-J. Lee, A. Panzera, D. Rogawski, L. E. Greene, and E. Eisenberg Cellular prion protein (PrPC) protects neuronal cells from the effect of huntingtin aggregation J. Cell Sci., August 1, 2007; 120(15): 2663 - 2671. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liang, Y. Pan, D. Zhang, C. Guo, Y. Shi, J. Wang, Y. Chen, X. Wang, J. Liu, X. Guo, et al. Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS FASEB J, July 1, 2007; 21(9): 2247 - 2256. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jodoin, S. Laroche-Pierre, C. G. Goodyer, and A. C. LeBlanc Defective Retrotranslocation Causes Loss of Anti-Bax Function in Human Familial Prion Protein Mutants J. Neurosci., May 9, 2007; 27(19): 5081 - 5091. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Li, S. J. Barmada, K. A. Roth, and D. A. Harris N-Terminally Deleted Forms of the Prion Protein Activate Both Bax-Dependent and Bax-Independent Neurotoxic Pathways J. Neurosci., January 24, 2007; 27(4): 852 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sunyach, M. A. Cisse, C. A. da Costa, B. Vincent, and F. Checler The C-terminal Products of Cellular Prion Protein Processing, C1 and C2, Exert Distinct Influence on p53-dependent Staurosporine-induced Caspase-3 Activation J. Biol. Chem., January 19, 2007; 282(3): 1956 - 1963. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Pan, L. Zhao, J. Liang, J. Liu, Y. Shi, N. Liu, G. Zhang, H. Jin, J. Gao, H. Xie, et al. Cellular prion protein promotes invasion and metastasis of gastric cancer FASEB J, September 1, 2006; 20(11): 1886 - 1888. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Li and D. A. Harris Mammalian Prion Protein Suppresses Bax-induced Cell Death in Yeast J. Biol. Chem., April 29, 2005; 280(17): 17430 - 17434. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Drisaldi, J. Coomaraswamy, P. Mastrangelo, B. Strome, J. Yang, J. C. Watts, M. A. Chishti, M. Marvi, O. Windl, R. Ahrens, et al. Genetic Mapping of Activity Determinants within Cellular Prion Proteins: N-TERMINAL MODULES IN PrPC OFFSET PRO-APOPTOTIC ACTIVITY OF THE DOPPEL HELIX B/B' REGION J. Biol. Chem., December 31, 2004; 279(53): 55443 - 55454. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |